| Symbol | PSTV |
|---|---|
| Name | PLUS THERAPEUTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 4200 MARATHON BOULEVARD,SUITE 200, AUSTIN, Texas, 78756, United States |
| Telephone | +1 737 255-7194 |
| Fax | — |
| — | |
| Website | https://www.plustherapeutics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001095981 |
| Description | Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Additional info from NASDAQ: |
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
Read morePlus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Read moreNew Form EFFECT - PLUS THERAPEUTICS, INC. <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 9999999995-26-001913 <b>Size:</b> 1 KB
Read more(99% Neutral) PLUS THERAPEUTICS, INC. (PSTV) Announces Business Combination
Read moreNew Form S-3/A - PLUS THERAPEUTICS, INC. <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0001193125-26-258388 <b>Size:</b> 436 KB
Read morePlus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
Read morePlus CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
Read morePlus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
Read moreHawkins Richard J 🟢 acquired 7.4K shares (2 derivative) of PLUS THERAPEUTICS, INC. (PSTV) at $5.76 Transaction Date: May 14, 2026 | Filing ID: 228930
Read more